Alector, Inc. (ALEC) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Alector, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:05.111 Good afternoon, ladies and gentlemen, and welcome to the Elector second quarter and 00:00:05.111 -- 00:00:10.194 mid-year 2024 earnings conference call. At this time, all participants are 00:00:10.194 -- 00:00:14.696 in listen-only mode. After the speaker's presentation, there will be a question and answer 00:00:14.696 -- 00:00:19.818 session. To ask a question during the session, you will need to press star 1-1 on your 00:00:19.818 -- 00:00:24.941 telephone. You will then hear an automated message advising your hand is raised. 00:00:24.941 -- 00:00:28.737 To withdraw your question, please press star 1-1 again. 00:00:28.737 -- 00:00:31.038 As a reminder, this conference call is being recorded. 00:00:31.038 -- 00:00:36.282 I would now like to turn the call over to Katie Hogan, Senior Director of Corporate 00:00:36.282 -- 00:00:41.484 Communications and Investor Relations. Please go ahead. 00:00:41.585 -- 00:00:46.708 Thank you, Operator, and hello, everyone. Earlier this afternoon, we released our financial 00:00:46.708 -- 00:00:52.312 results for the second quarter, 2024. The press release is available on our website 00:00:52.312 -- 00:00:54.692 at www.elector.com. 00:00:55.290 -- 00:00:59.833 And our 10-Q is filed with the Securities and Exchange Commission this afternoon. 00:00:59.833 -- 00:01:04.977 Joining me on the call today are Dr. Arnon Rosenthal, co-founder and CEO, Dr. 00:01:04.977 -- 00:01:09.620 Sarah Kankari-Nitra, President and Head of Research and Development, Dr. 00:01:09.620 -- 00:01:13.002 Gary Romano, Chief Medical Officer, and Dr. 00:01:13.002 -- 00:01:16.384 Mark Grasso, Chief Financial Officer. 00:01:16.384 -- 00:01:20.027 After our formal remarks, we'll open the call for Q&A. 00:01:20.027 -- 00:01:24.175 I'd ...